N@N

Market Maker Surveillance Report. DELT, HMNY, OPXA, EBS, SKYAY, ACIU, Winning Stocks With Lowest Price Friction For Friday, De

^{Published on 2016-12-09 18:47:20 - WOPRAI}
 

December 9, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5554 companies with "abnormal" market making, 3314 companies with positive Friction Factors and 2871 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Delta Galil Industries Ltd. (NASDAQ:DELT), Helios and Matheson Analytics Inc. (NASDAQ:HMNY), Opexa Therapeutics Inc. (NASDAQ:OPXA), Emergent BioSolutions Inc. (NYSE:EBS), Sky (OTC:SKYAY), AC Immune (NASDAQ:ACIU). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  DELT    $0.290    0.40%     98,869       58.88%    29,167       17.37%    69,702       2,404   
  HMNY    $0.970    0.23%     683,451      38.81%    663,707      37.68%    19,744       204     
  OPXA    $0.350    0.41%     3,951,372    38.81%    3,878,956    38.09%    72,416       2,069   
  EBS     $5.150    0.19%     780,695      38.69%    680,530      33.73%    100,165      194     
  SKYAY   $10.290   0.26%     38,459       44.96%    27,711       32.40%    10,748       10      
  ACIU    $2.880    0.24%     157,919      38.16%    148,950      35.99%    8,969        31      

For example, the chart above shows DELT with a dollar gain Friday of $0.29000 and a Friction Factor of 2,404 shares. That means that it only took 2,404 more shares of buying than selling to move DELT higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Delta Galil Industries Ltd. (NASDAQ:DELT) - Delta Galil Industries Ltd. (Delta Galil), incorporated in 1975, together with its subsidiaries, is a global manufacturer and marketer of private-label ladies' intimate apparel, men's underwear, socks, shirts, babywear, bras, leisurewear and nightwear, knitted fabrics, dyeing, trimmings and elastic ribbons. The Company sells its products to retailers, including Marks & Spencer, Victoria's Secret, Kmart, Wal-Mart, Hema, Mervyn's, Target and JC Penney, as well as to marketers, including Calvin Klein, Nike, Hugo Boss and Pierre Cardin. The Company sells its products under brand names, including Wilson, Barbie, Maidenform, Nicole Miller, and Levi?s Signature in Europe. It also sells its products in Israel under the Delta brand name. Delta Galil works with its customers to design and manufacture knitwear. It produces a variety of products using cotton and man-made fibers.

Delta Galil maintains long-term relationships with its customers. During the year ended December 31, 2005, the Company's five largest customers in North America, Wal-Mart, Target, Victoria's Secret, JC Penney and Calvin Klein, represented approximately 78% of sales in North America. Of Delta Galil's sales in Israel, 42% were made through retail department stores and supermarkets, and 58% were made through Delta Galil's Delta Plus chain stores. As of December 31, 2005, Delta Plus had 83 stores.

Ladies' Intimate Apparel

Delta Galil's intimate apparel items include fashion and basic underwear, as well as bras. It has introduced machinery to produce seam-free panties, tops and control underwear. The Company has been shifting its product mix to increase its focus on these products. During 2005, ladies' intimate apparels accounted for 61% of the Company's total revenues.

Socks

The Company manufactures men's, women's and children's socks in the leisure, dress and sports categories. Among the varieties of socks that it manufactures are socks with popular cartoon and other characters that it licenses. During 2005, socks accounted for 20% of the Company's total revenues.

Men's Underwear

Delta Galil manufactures men's fashion and basic underwear for customers that include marketers of fashion brands and department store private labels. During 2005, men's underwear accounted for 11% of the Company's total revenues.

Babywear

Babywear includes fashion and classic daywear and sleepsuits in a variety of styles and fabrics, with a focus on newborns. The Company's products in this category are sold at medium to high-retail prices. During 2005, babywear accounted for 3% of the Company's total revenues.

Leisurewear

Delta Galil manufactures basic and fashion leisurewear in a variety of styles and fabrics. The products range from T-shirts, polo shirts, sweatshirts and jogging suits to leisure and fashionable blouson jackets that are sold at medium to high-retail prices. During 2005, leisurewear accounted for 3% of the Company's total revenues.

Others

The Company's other products include fabrics, elastic tapes and other operations. During 2005, other products accounted for 2% of the Company's total revenues..

Helios and Matheson Analytics Inc. (NASDAQ:HMNY) - HARMONY GROUP LTD.

Opexa Therapeutics Inc. (NASDAQ:OPXA) - Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company s lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is based in The Woodlands, Texas..

Emergent BioSolutions Inc. (NYSE:EBS) - Emergent BioSolutions Inc., a specialty biopharmaceutical company, focuses on the development, manufacture, and distribution of a portfolio of vaccines, therapeutics, and other novel products and related services for civilian and military populations in the United States. Its products address public health threats, primarily chemical, biological, radiological, nuclear and explosive, or CBRNE threats, as well as infectious diseases. The company s marketed products include BioThrax, an anthrax vaccine; Anthrasil, a polyclonal antibody for the treatment of inhalational anthrax; BAT (Botulism Antitoxin Heptavalent) for the treatment of botulinum disease; VIGIV (Vaccinia Immune Globulin Intravenous) that addresses adverse events from smallpox vaccination; and reactive skin decontamination lotion kit for the removal or neutralization of chemical agents, T-2 toxin and various pesticide-related chemicals from the skin. Its investigational stage product candidates include NuThrax, a next generation anthrax vaccine; UV-4B for dengue and influenza infections; GC-072 for Burkholderia pseudomallei; VAX161C, a recombinant pandemic influenza vaccine; and other products addressing public health threats and emerging infectious diseases. In addition, the company provides contract manufacturing services to third-party customers. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland..

Sky (OTC:SKYAY) - .

AC Immune (NASDAQ:ACIU) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net